Gaucher’s drug approved

(Thanks to Israel21c and Globes) Elelyso – a new treatment for Gaucher’s disease, from Israel’s Protalix BioTherapeutics, is set to hit pharmacies around the globe, following approval by the American Food and Drug Administration. The drug has been licensed to Pfizer.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *